Why is Parmax Pharma falling/rising?

As of 25-Jul, Parmax Pharma Ltd is experiencing a decline in its stock price, currently at Rs 37.77, which represents a decrease of 1.72 or 4.36%. The stock has underperformed its sector by 4.53% today and has touched an intraday low of Rs 37.77. Over the past week, the stock has seen a significant drop of 7.56%, and its performance over the last month is also negative at 7.45%. Additionally, the stock is trading below all its moving averages, indicating a bearish trend. Despite declaring positive results for the last three consecutive quarters, the company has a negative book value and weak long-term fundamental strength, which contributes to the stock's downward movement.
In the broader market context, the Sensex has only declined by 0.36% over the past week, indicating that Parmax Pharma's performance is significantly worse than the benchmark. The company's weak ability to service its debt, coupled with a negative operating profit and poor long-term growth rates, further exacerbates investor concerns. While the stock has generated a return of 3.82% over the past year, the underlying financial issues, including a poor EBIT to Interest ratio, suggest that investors may be cautious, leading to a decrease in participation and liquidity in the stock.